20Lighter Announces Issuance Of First US Patent For Visceral Fat Reduction
The Floridant/10067218

BOCA RATON, Fla. - Floridant -- 20Lighter, LLC., a leading consumer health company primarily focused on obesity and cardiometabolic disease with innovative comprehensive programs, today announced that the United States Patent and Trademark Office has issued US Patent 10,638,786, entitled "Methods of Reducing Visceral Fat and Related Compositions". The company's first issued patent covers the use of uniquely designed and implemented nutritional plans without prepackaged foods or meal replacements to significantly reduce visceral adipose tissue, also known as visceral fat or abdominal obesity. This proprietary technology is a foundation of the company's flagship programs delivering health benefits that extend far beyond weight loss.

"We are incredibly proud of this accomplishment, as it provides a strong foundation for 20Lighter to continue changing lives and the weight loss industry with innovation and results that go beyond the scale," said Dr. Jessica Barnes, CEO of 20Lighter. "This is an amazing step forward for our company and a continuation application already submitted builds upon this initial patent. 20Lighter is an innovator in the weight loss industry and we are very excited to add this patent as yet another differentiating factor."

More on The Floridant
About 20Lighter, LLC

20Lighter is a revolutionary program tackling obesity and cardiometabolic disease by targeting causative factors on physiological, nutritional, and behavioral levels. Its unique multimodal design and breakthrough strategy delivers dramatic reductions of inflammation and visceral fat, the holy grail of cardiovascular and metabolic disease resulting in sustainable clinically meaningful improvements in overall health and enhanced quality of life.

More information about the company can be found at www.20Lighter.com

Jessica W. Barnes, Ph.D
CEO & Co-Founder

Source: 20Lighter, LLC
Filed Under: Consumer, Health

Show All News | Report Violation


Latest on The Floridant